PT1007096E - Complexo de silicato de arginina inositol e a sua utilizacao - Google Patents
Complexo de silicato de arginina inositol e a sua utilizacaoInfo
- Publication number
- PT1007096E PT1007096E PT98905010T PT98905010T PT1007096E PT 1007096 E PT1007096 E PT 1007096E PT 98905010 T PT98905010 T PT 98905010T PT 98905010 T PT98905010 T PT 98905010T PT 1007096 E PT1007096 E PT 1007096E
- Authority
- PT
- Portugal
- Prior art keywords
- pct
- arginine
- silicate
- complex
- inositol
- Prior art date
Links
- 239000004475 Arginine Substances 0.000 title 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 title 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 title 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 title 1
- 229960000367 inositol Drugs 0.000 title 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 title 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/04—Esters of silicic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/799,784 US5707970A (en) | 1997-02-12 | 1997-02-12 | Arginine silicate complex and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1007096E true PT1007096E (pt) | 2004-03-31 |
Family
ID=25176739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98905010T PT1007096E (pt) | 1997-02-12 | 1998-02-11 | Complexo de silicato de arginina inositol e a sua utilizacao |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US5707970A (enExample) |
| EP (1) | EP1007096B1 (enExample) |
| JP (1) | JP2001512443A (enExample) |
| KR (1) | KR20000070977A (enExample) |
| CN (1) | CN1182873C (enExample) |
| AT (1) | ATE251914T1 (enExample) |
| AU (1) | AU722975B2 (enExample) |
| BR (1) | BR9807675A (enExample) |
| CA (1) | CA2279233A1 (enExample) |
| DE (1) | DE69819016T2 (enExample) |
| DK (1) | DK1007096T3 (enExample) |
| ES (1) | ES2209112T3 (enExample) |
| HU (1) | HUP0001998A3 (enExample) |
| IL (1) | IL130925A0 (enExample) |
| PT (1) | PT1007096E (enExample) |
| WO (1) | WO1998034647A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5707970A (en) | 1997-02-12 | 1998-01-13 | Nutrition 21 | Arginine silicate complex and use thereof |
| US20020068365A1 (en) * | 1998-07-28 | 2002-06-06 | Eric H. Kuhrts | Controlled release nitric oxide producing agents |
| AU2001281337A1 (en) * | 2000-07-24 | 2002-02-05 | Nutrition 21, Inc. | Arginine saccharate and use thereof |
| US6552074B2 (en) * | 2000-11-16 | 2003-04-22 | Fukumi Morishige | Arginine/ascorbic acid mixed powder as an oral supplement |
| TWI283427B (en) * | 2001-07-12 | 2007-07-01 | Semiconductor Energy Lab | Display device using electron source elements and method of driving same |
| US7147661B2 (en) * | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
| EP1467679B1 (en) * | 2001-12-20 | 2015-11-04 | TriVascular, Inc. | Advanced endovascular graft |
| US20040097467A1 (en) * | 2002-08-22 | 2004-05-20 | Vijaya Juturu | Arginine silicate inositol complex and use thereof |
| US6803456B1 (en) * | 2003-08-13 | 2004-10-12 | Rutherford Chemicals Llc | Process for the production of arginine-silicate complex |
| US7803178B2 (en) * | 2004-01-30 | 2010-09-28 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
| CA2558573A1 (en) * | 2004-03-11 | 2005-09-22 | Trivascular, Inc. | Modular endovascular graft |
| US7964219B2 (en) * | 2004-08-12 | 2011-06-21 | Qps, Llc | Pharmaceutical compositions for controlled release delivery of biologically active compounds |
| US7919620B2 (en) * | 2005-06-01 | 2011-04-05 | Coral Biotech Kabushiki Kaisha | Agent for suppressing blood pressure elevation |
| ITMI20060677A1 (it) * | 2006-04-06 | 2007-10-07 | Damor Farmaceutici | Profarmaci dell'arginina ad elevata attivita'terapeutica |
| US20100143488A1 (en) * | 2006-09-21 | 2010-06-10 | Toshiki Oguro | Promoter of hard tissue regeneration |
| WO2008112706A1 (en) | 2007-03-13 | 2008-09-18 | Nutrition 21, Inc. | Methods and compositions for the sustained release of chromium |
| WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
| GB0805279D0 (en) | 2008-03-20 | 2008-04-30 | Univ Nottingham Trent | Food supplement |
| WO2012035364A1 (en) | 2010-09-15 | 2012-03-22 | Creogen D.O.O. | Stabilized solution of ortho-silicic acid, its preparation and use |
| EP4070801A1 (en) | 2011-03-01 | 2022-10-12 | Nutrition 21, LLC | Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders |
| US11191735B2 (en) | 2015-03-13 | 2021-12-07 | Nutrition 21, Llc | Arginine silicate for periodontal disease |
| ES2797688T3 (es) * | 2015-06-30 | 2020-12-03 | Nutrition 21 Llc | Arginina silicato inositol para mejorar la función cognitiva |
| EP3322661B1 (en) | 2015-07-13 | 2022-03-02 | Otis Elevator Company | Deterrent device inhibition key |
| US20170135969A1 (en) | 2015-11-12 | 2017-05-18 | Jds Therapeutics, Llc | Topical arginine-silicate-inositol for wound healing |
| MX2018009748A (es) | 2016-02-11 | 2019-02-07 | Nutrition 21 Llc | Composiciones que contienen cromo para mejorar la salud y el estado físico. |
| JP2019526638A (ja) | 2016-09-01 | 2019-09-19 | ジェイディーエス・セラピューティクス、エルエルシー | ビオチン酸マグネシウム組成物および使用方法 |
| WO2020092431A1 (en) * | 2018-11-02 | 2020-05-07 | Nutrition 21, Llc | Compositions containing inositol-stabilized arginine silicate complexes and inositol for improving cognitive function in video gamers |
| AU2020407071A1 (en) | 2019-12-16 | 2022-07-07 | Nutrition 21, Llc | Methods of production of arginine-silicate complexes |
| US20250024860A1 (en) * | 2021-11-12 | 2025-01-23 | Nutrition21, LLC | Compositions and methods for treating or preventing myopathy in poultry |
| CN118206406B (zh) * | 2024-03-20 | 2025-08-15 | 山东农业大学 | 精氨酸硅酸盐肌醇络合物在提高作物果实品质中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3337403A (en) * | 1963-09-05 | 1967-08-22 | Hoffmann La Roche | Stable and palatable pharmaceutical compositions |
| US4297349A (en) * | 1980-04-15 | 1981-10-27 | Sandoz, Inc. | Silicon-bearing carboxylic acids and amides |
| US4385052A (en) * | 1981-07-20 | 1983-05-24 | International Plant Research Institute, Inc. | Use of trialkylsilyl-6-aminonicotinamides for the treatment of psoriasis |
| FR2610522B1 (fr) * | 1987-02-06 | 1989-08-18 | Gueyne Jean | Produit therapeutique a base de derives organiques du silicium |
| US5250569A (en) * | 1991-04-22 | 1993-10-05 | Godfrey Science & Design, Inc. | Amino acid flavorings of aluminum astringent for oral use |
| US5622980A (en) * | 1993-08-17 | 1997-04-22 | Applied Analytical Industries, Inc. | Oral compositions of H2-antagonists |
| FR2745498A1 (fr) * | 1996-02-29 | 1997-09-05 | Giroux Jean Marc | Composition pur augmenter conjointement la tolerance biologique et l'efficacite amincissante des produits hyperproteines hypocaloriques destines au traitement de l'obesite |
| US5707970A (en) * | 1997-02-12 | 1998-01-13 | Nutrition 21 | Arginine silicate complex and use thereof |
-
1997
- 1997-02-12 US US08/799,784 patent/US5707970A/en not_active Expired - Lifetime
-
1998
- 1998-02-11 DE DE69819016T patent/DE69819016T2/de not_active Expired - Fee Related
- 1998-02-11 AU AU62737/98A patent/AU722975B2/en not_active Ceased
- 1998-02-11 CA CA002279233A patent/CA2279233A1/en not_active Abandoned
- 1998-02-11 JP JP53496698A patent/JP2001512443A/ja not_active Ceased
- 1998-02-11 WO PCT/US1998/002443 patent/WO1998034647A1/en not_active Ceased
- 1998-02-11 KR KR1019997007243A patent/KR20000070977A/ko not_active Withdrawn
- 1998-02-11 US US09/367,267 patent/US6156735A/en not_active Expired - Lifetime
- 1998-02-11 ES ES98905010T patent/ES2209112T3/es not_active Expired - Lifetime
- 1998-02-11 EP EP98905010A patent/EP1007096B1/en not_active Expired - Lifetime
- 1998-02-11 AT AT98905010T patent/ATE251914T1/de not_active IP Right Cessation
- 1998-02-11 BR BR9807675-2A patent/BR9807675A/pt not_active Application Discontinuation
- 1998-02-11 HU HU0001998A patent/HUP0001998A3/hu unknown
- 1998-02-11 PT PT98905010T patent/PT1007096E/pt unknown
- 1998-02-11 DK DK98905010T patent/DK1007096T3/da active
- 1998-02-11 IL IL13092598A patent/IL130925A0/xx unknown
- 1998-02-11 CN CNB988023695A patent/CN1182873C/zh not_active Expired - Fee Related
-
2000
- 2000-12-05 US US09/730,895 patent/US6344444B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE251914T1 (de) | 2003-11-15 |
| EP1007096A1 (en) | 2000-06-14 |
| US5707970A (en) | 1998-01-13 |
| HUP0001998A3 (en) | 2002-01-28 |
| CN1182873C (zh) | 2005-01-05 |
| DE69819016D1 (de) | 2003-11-20 |
| CN1246801A (zh) | 2000-03-08 |
| CA2279233A1 (en) | 1998-08-13 |
| AU722975B2 (en) | 2000-08-17 |
| JP2001512443A (ja) | 2001-08-21 |
| WO1998034647A1 (en) | 1998-08-13 |
| US6344444B1 (en) | 2002-02-05 |
| BR9807675A (pt) | 2000-02-15 |
| KR20000070977A (ko) | 2000-11-25 |
| IL130925A0 (en) | 2001-01-28 |
| EP1007096B1 (en) | 2003-10-15 |
| AU6273798A (en) | 1998-08-26 |
| US6156735A (en) | 2000-12-05 |
| HUP0001998A2 (hu) | 2000-10-28 |
| DK1007096T3 (da) | 2003-12-01 |
| ES2209112T3 (es) | 2004-06-16 |
| DE69819016T2 (de) | 2004-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1007096E (pt) | Complexo de silicato de arginina inositol e a sua utilizacao | |
| ATE437393T1 (de) | Verfahren und vorrichtung zur bereitstellung eines entkoppelten leistungsverwaltungszustands | |
| DK1303632T3 (da) | Galactomannan-oligosaccharid og fremgangsmåde til fremstilling samt anvendelse heraf | |
| FI972164A0 (fi) | Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö | |
| CA2145899A1 (en) | Apparatus for transmitting and receiving executable application in a distributed computer system | |
| MXPA03001711A (es) | Metodo y sistema de evaluar comparativamente remuneraciones competitivas. | |
| BR9709048A (pt) | Sistema de informação | |
| ZA988158B (en) | Sulfinic acid derivatives and their preparation and use | |
| AU1694392A (en) | Determination of motifs of peptides on mhc molecules | |
| NO974514D0 (no) | Syntetisk HPV6/11 hydrud L1 DNA som koder for humant papillomavirus Type 11 L1-protein | |
| PL340561A1 (en) | Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders | |
| JP2001526309A5 (enExample) | ||
| BR9814486A (pt) | Sistema para analisar o desempenho decontrolador de gráfico | |
| PT888327E (pt) | Derivados de benzopirano que possuem uma accao antagonistica dos leucotrienos | |
| BG102814A (en) | New derivatives of carboxylic acid, their preparation and application | |
| MX9700053A (es) | Composiciones de descamacion. | |
| DE60117824D1 (de) | Orale zubereitung mit seetang zur reduzierung von plaque und calculus | |
| ES2163001T3 (es) | Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica. | |
| DK0841937T3 (da) | Anvendelse af betaglycan til reduktion af ardannelse | |
| NO995004D0 (no) | Anvendelse av bruskoligometrisk matriksprotein for behandling av reumatoid artritt | |
| ATE227115T1 (de) | Mittel zur orale hygiene | |
| FR2740772B1 (fr) | Procede de preparation d'anthraquinones substituees et application a la preparation de rheines | |
| ATE251368T1 (de) | Verfahren und vorrichtung zur reduzierung des leistungsverbrauchs in einem öffentlichem fernsprechgerät | |
| BR9800781A (pt) | Processo e dispositibo para o acionamento de uma caixa de cmbio | |
| DK0891322T3 (da) | Dimethylsubstituerede cyclohexandienderivater |